0001140361-14-032106.txt : 20140813 0001140361-14-032106.hdr.sgml : 20140813 20140813123330 ACCESSION NUMBER: 0001140361-14-032106 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140813 DATE AS OF CHANGE: 20140813 EFFECTIVENESS DATE: 20140813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Trimel Pharmaceuticals Corp CENTRAL INDEX KEY: 0001527246 IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-222821 FILM NUMBER: 141036553 BUSINESS ADDRESS: STREET 1: 2488 DUNWIN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5L 1J9 BUSINESS PHONE: 1 416 679 0771 MAIL ADDRESS: STREET 1: 2488 DUNWIN DRIVE CITY: MISSISSAUGA STATE: A6 ZIP: L5L 1J9 D 1 primary_doc.xml X0707 D LIVE 0001527246 Trimel Pharmaceuticals Corp 2488 DUNWIN DRIVE MISSISSAUGA A6 ONTARIO, CANADA L5L 1J9 416-679-0771 ONTARIO, CANADA None None Corporation true 2009 Tom Rossi 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Executive Officer Director Kenneth Howling 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Executive Officer Nathan Bryson 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Executive Officer Matthew Hawkins 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Executive Officer Rolf K. Reininghaus 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Executive Officer Director Ian Ihnatowycz 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Director John Friedrichsen 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Director Stephen Gregory 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Director Matthew Pfeffer 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Executive Officer D. Lorne Tyrell 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Director Jeffrey Sherman 2488 Dunwin Drive Mississauga A6 ONTARIO, CANADA L5L 1J9 Director Pharmaceuticals Decline to Disclose 06b false 2014-07-30 false true false 0 Cormark Securities Inc. None Cormark Securities (U.S.A.) Limited 101000 200 Bay Street Royal Bank Plaza, South Tower Toronto A6 ONTARIO, CANADA M5J 2J2 NY NEW YORK false 2131268 2131268 0 false 2 117220 0 2131268 The Company paid the proceeds to First Generation Capital Inc. (?FGI?), a company affiliated with Mr. Ihnatowyca (Chairman). As at the date hereof, FGI beneficially owns, controls or directs, 20% of the shares of the Company. false Trimel Pharmaceuticals Corp /s/ Kenneth Howling Kenneth Howling Chief Financial Officer 2014-08-05